Friday, May 22, 2015 | Latest E-book
You are here:
Novartis
#

Novartis

Articles

View all

Natco Pharma gains 4.5% after filing ANDA with USFDA

Feb 10, 2015

Natco Pharma gains 4.5% after filing ANDA with USFDA

Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer. #India #US #Generic drug #generic drug makers #Sanofi #Natco Pharma #Novartis #Jevtana #ANDA #Cabazitaxel #Fingolimod #Gilenya
Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drug

Jan 14, 2015

Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drug

Cipla, India's fourth-largest generic drugmaker by revenue, had launched its copy of Onbrez in New Delhi in October last year at a fifth of the original drug's price, citing urgent unmet need in India. #India #NewsTracker #Delhi High Court #Cipla #Novartis #respiratory drug #Onbrez
To the brink and back: Key business events in 2013

Dec 31, 2013

To the brink and back: Key business events in 2013

The RBI starting the year off with rate cuts and then reversing its stance on concerns about widening current account deficit. Fears that the US Federal Reserve will start cutting its bond purchase programme sooner than expected only added to the worries. Foreign funds pulled out of the Indian equities and debt in hoards. #Infosys #Inflation #Gold #P. Chidambaram #RBI #Rupee #Ben Bernanke #Phaneesh Murthy #Narayana Murthy #WPI #US Federal Reserve #Raghuram Rajan #Tesco #Ambani #Pepsi #iGate #CPI #CAD #Jignesh Shah #Novartis #NSEL #taper #Tata Trent #RearView2013
Pharma sector registers single digit growth in 2013; regulators increase scrutiny

Dec 29, 2013

Pharma sector registers single digit growth in 2013; regulators increase scrutiny

The Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers. #FDI #Cipla #Sun Pharmaceuticals #Wockhardt #Ranbaxy #Pharma #Torrent Pharmaceuticals #WTO #Biocon #gsk #Pfizer #Piramal Enterprises #USFDA #Novartis #Dr. Reddy #RearView2013 #Elder #IPAB #Zydus #Cadilla

BLOG POSTS

View all

Why a global fight against cancer is a good idea

Apr 10, 2013

Why a global fight against cancer is a good idea

In a substantive paper published today in the journal Nature Reviews, a group of authors from Singapore, the USA and Brazil evaluate the cost of cancer medication in low and middle income countries. #WhyNow #Cancer #Healthcare #Diabetes #Novartis #glivec #Merck #Dabur Pharma